Ocugen_March_2021_454_67454
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ocugen's March 2021 presentation outlines its mission to develop gene therapies for blindness and a COVID-19 vaccine, highlighting forward-looking statements and market insights.
